BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27376763)

  • 41. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study.
    Cicione A; De Nunzio C; Tubaro A; Cantiello F; Manno S; Oliveira C; Lima E; Damiano R
    BMC Cancer; 2016 Feb; 16():59. PubMed ID: 26846521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression.
    Wong LM; Toi A; Van der Kwast T; Trottier G; Alibhai SM; Timilshina N; Evans A; Zlotta A; Fleshner N; Finelli A
    J Urol; 2014 Oct; 192(4):1088-93. PubMed ID: 24742593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
    Cary KC; Cowan JE; Sanford M; Shinohara K; Perez N; Chan JM; Meng MV; Carroll PR
    Eur Urol; 2014 Aug; 66(2):337-42. PubMed ID: 24035632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing prostate cancer detection during biopsy by standardizing the amount of tissue examined per core.
    Sfakianos JP; Thorner DA; Dovirak O; Weiss JP; Karanikolas NT
    BJU Int; 2011 Nov; 108(10):1578-81. PubMed ID: 21627750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients.
    Suardi N; Gallina A; Capitanio U; Salonia A; Lughezzani G; Freschi M; Mottrie A; Rigatti P; Montorsi F; Briganti A
    Cancer; 2012 Feb; 118(4):973-80. PubMed ID: 21751185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
    Roehrborn CG; Andriole GL; Wilson TH; Castro R; Rittmaster RS
    Eur Urol; 2011 Feb; 59(2):244-9. PubMed ID: 21093145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
    Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
    Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: a 12 months analysis after three consecutive prostate biopsies.
    De Nunzio C; Albisinni S; Cicione A; Gacci M; Leonardo C; Esperto F; Tubaro A
    Arch Ital Urol Androl; 2013 Jun; 85(2):59-64. PubMed ID: 23820650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings.
    Inahara M; Suzuki H; Kojima S; Komiya A; Fukasawa S; Imamoto T; Naya Y; Ichikawa T
    Urology; 2006 Oct; 68(4):815-9. PubMed ID: 17070359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 7 to 10 years' follow-up of 573 patients with elevated prostate-specific antigen (>4 ng/mL) or/and suspected rectal examination: biopsies protocol and follow-up guides.
    Kravchick S; Cytron S; Stepnov E; Ben-Dor D; Kravchenko Y; Peled R
    J Endourol; 2009 Jun; 23(6):1007-13. PubMed ID: 19456240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of 17-β-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.
    De Nunzio C; Lombardo R; Leonardo C; Franco G; Gacci M; Presicce F; Cancrini F; Tubaro A
    Urol Oncol; 2014 Jan; 32(1):35.e9-13. PubMed ID: 23510864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
    Isbarn H; Karakiewicz PI; Vogel S; Jeldres C; Lughezzani G; Briganti A; Montorsi F; Perrotte P; Ahyai SA; Budäus L; Eichelberg C; Heuer R; Köllermann J; Sauter G; Schlomm T; Steuber T; Haese A; Zacharias M; Fisch M; Heinzer H; Huland H; Chun FK; Graefen M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):784-7. PubMed ID: 19864083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate.
    Paul R; Korzinek C; Necknig U; Niesel T; Alschibaja M; Leyh H; Hartung R
    Urology; 2004 Sep; 64(3):532-6. PubMed ID: 15351585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical value of core length in contemporary multicore prostate biopsy.
    Lee S; Jeong SJ; Hwang SI; Hong SK; Lee HJ; Byun SS; Choe G; Lee SE
    PLoS One; 2015; 10(4):e0123704. PubMed ID: 25875823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy.
    Roscigno M; Scattoni V; Freschi M; Abdollah F; Maccagnano C; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Deiana G; Belussi D; Chinaglia D; Montorsi F; Da Pozzo LF
    BJU Int; 2012 May; 109(9):1329-34. PubMed ID: 21895935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy.
    Lee WK; Lee S; Hong SK; Lee SE; Choi WS; Byun SS
    Int Braz J Urol; 2014; 40(4):484-92. PubMed ID: 25251953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.